Recent analyses of DDIT4 in several cancer types have shown that high expression of this gene is associated with poor prognosis in several hematological and solid tumors, such as acute myeloid leukemia (67), breast cancer (68) and lung cancer (69). The gene discussed is DDIT4; the disease is cancer.